Good Health Can’t Wait.

Standalone Financial Statements Annual Report 2014 - 15
NOTES TO FINANCIAL STATEMENTS
(All amounts in Indian Rupees millions, except share data and where otherwise stated)
2.43: ACQUISITION OF SELECT ESTABLISHED BRAND PORTFOLIO OF UCB
On 1 April 2015, the Company entered into a definitive agreement with UCB India Private Limited and other UCB group companies (together referred to
as “UCB”) to acquire a select portfolio of established products business in the territories of India, Nepal, Sri Lanka and Maldives. The said business was
acquired on a slump sale basis. The transaction includes approximately 350 employees engaged in operations of the India Business. The acquisition is
expected to strengthen the Company’s presence in the areas of Dermatology, Respiratory and Pediatrics. The total purchase consideration was ` 8,000.
The acquisition is expected to be closed in the first quarter of the financial year 2015-16.
2.44: SEGMENT INFORMATION
In accordance with AS-17 “Segment Reporting”, segment information has been given in the consolidated financial statements of Dr. Reddy’s Laboratories
Limited and therefore no separate disclosure on segment information is given in these financial statements.
2.45: FINANCE LEASE
The Company has taken vehicles on finance lease. The future minimum lease payments and their present values as at 31March2015 are as follows:
PARTICULARS
PRESENT VALUE OF
MINIMUM LEASE
PAYMENTS
FUTURE INTEREST
MINIMUM LEASE
PAYMENTS
Not later than one year 6 7 13
Later than one year and not later than five years 8 4 12
Total 14 11 25
The future minimum lease payments and their present values as at 31March2014 were as follows:
PARTICULARS
PRESENT VALUE OF
MINIMUM LEASE
PAYMENTS
FUTURE INTEREST
MINIMUM LEASE
PAYMENTS
Not later than one year 4 9 13
Later than one year and not later than five years 13 11 24
Total 17 20 37
2.46: OPERATING LEASE
The Company has taken offices and vehicles under operating lease agreements. Total expense recognised in statement of profit and loss on account of
operating leases during the year amounts to ` 277 (previous year: ` 380).
The total future minimum lease payments under non cancellable leases are as follows:
PARTICULARS
AS AT
31 MARCH 2015
AS AT
31 MARCH 2014
Not later than one year 81 72
Later than one year and not later than five years 96 85
Total 177 157
2.47: COMPARATIVE FIGURES
Previous year’s figures have been regrouped / reclassified wherever necessary, to conform to current year’s classification.
As per our report of even date attached
for B S R & Co. LLP
Chartered Accountants
for and on behalf of the Board of Directors of Dr. Reddy’s Laboratories Limited
Firm Registration No.: 101248W/W-100022
Supreet Sachdev
Partner K Satish Reddy Chairman
Membership No.: 205385 G V Prasad Co-Chairman & Chief Executive Officer
Place : Hyderabad Saumen Chakraborty President & Chief Financial Officer
Date : 12 May 2015 Sandeep Poddar Company Secretary
161